PATENT CLAIM ANALYSIS

Application Number: 15948718
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["514", "330000"]

Abstract:
The present invention relates to compositions comprising a lipophilic local anaesthetic, preferably bupivacaine or a pharmaceutically active salt thereof, which are formulated for local administration to the mouth or throat of a subject. The compositions are useful in the treatment or alleviation of pain, burning or xerostomia of the oral cavity, pharynx, oral mucosa and pharyngeal mucosa or for use in providing local anesthesia of the oral cavity, pharynx, oral mucosa and pharyngeal mucosa. In particular in the treatment of pain, burning or xerostomia, which is caused by a disease such as oral mucositis, Burning Mouth Syndrome, Sjogren's syndrome, xerostomia, periodontitis, toothache, tonsillectomy, throat infection or mononucleosis, canker sores and aphthous stomatitis.

Claim (Index 12):
The sustained-release composition according to  claim 1 , wherein the bupivacaine or pharmaceutically active salt thereof is the only active ingredient.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.9
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14114669', '12420177', '14612143', '13899845', '15293535']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.731359696583571
- 35 USC 102 Novelty (BERT): 0.6021566013254752
- Combined Prediction Score: 0.7184393870577614
- Mean Citation Score: 279.98602600000004
- Max Citation Score: 545.5008
- Similarity Product: 429.66408936195376

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test